Document Detail

Anticonvulsants to treat post-traumatic stress disorder.
MedLine Citation:
PMID:  25131430     Owner:  NLM     Status:  Publisher    
OBJECTIVE: We reviewed the existing literature on the efficacy of anticonvulsants in treating post-traumatic stress disorder.
METHODS: We performed a literature search using PubMed, EMBASE and the Cochrane database on 30 September 2013. Randomized, controlled studies that investigated the efficacy of anticonvulsants for post-traumatic stress disorder were included in this review. Studies with retrospective designs, case reports and case series were excluded.
RESULTS: A total of seven studies met the inclusion criteria for this review. Three studies used topiramate with negative findings regarding its efficacy. Two studies used divalproex, both of which failed to show superiority over placebo. One study used lamotrigine, with favourable results, and one study used tiagabine, with negative results.
CONCLUSIONS: Future long-term studies with larger sample sizes are needed to investigate the clinical utility of anticonvulsants for post-traumatic stress disorder treatment. Copyright © 2014 John Wiley & Sons, Ltd.
Hee Ryung Wang; Young Sup Woo; Won-Myong Bahk
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-11
Journal Detail:
Title:  Human psychopharmacology     Volume:  -     ISSN:  1099-1077     ISO Abbreviation:  Hum Psychopharmacol     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8702539     Medline TA:  Hum Psychopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 John Wiley & Sons, Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Development and evaluation of the Stages of Change in Oral Health instrument.
Next Document:  Allopurinol and its role in the treatment of sarcopenia.